Analyst Research

Report Title Price
Provider: GlobalData
$125.00
Provider: Finlabo SIM Spa
$10.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

DiaSorin SpA Confirms FY 2013 Revenues and EBITDA Guidance


Thursday, 1 Aug 2013 07:34am EDT 

DiaSorin SpA announced that it confirmed the Company's revenues and EBITDA guidance for fiscal year 2013. The confirmation is in view of the Group's operating performance after June 30, 2013 and taking into account possible evolutions of the global macroeconomic scenario and the diagnostic sector in particular. The Company expects to report for fiscal year 2013 revenues with a growth rate between 2% and 4% at CER compared with fiscal year 2012, and EBITDA in line with the absolute value of fiscal year 2012 at CER. For fiscal year 2012 the Company reported revenues of EUR 433.76 million and EBITDA of EUR 169.56 million. According to I/B/E/S Estimates, analysts on average are expecting the Company to report for fiscal year 2013 revenues of EUR 444.75 million and EBITDA of EUR 170.30 million. 

Company Quote

32.75
0.13 +0.40%
17 Dec 2014